Results 51 to 60 of about 3,128,159 (361)
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
Frontiers in Oncology, 2021 Most pituitary tumors are considered benign adenomas, and only 0.1%–0.2% of them present metastasis and are defined as pituitary carcinomas (PCs). Refractory pituitary adenomas (PAs) lie between benign adenomas and true malignant PCs and are defined as ...
Congxin Dai +4 more
doaj +1 more source
Management of pituitary spindle cell oncocytomas: A case report and review of the literature
Interdisciplinary Neurosurgery, 2021 Pituitary spindle cell oncocytomas represent a rare pathologic entity within the differential diagnosis for pituitary tumors. As part of a class of tumors that includes low grade non-endocrine pituitary tumors such as pituicytomas and granular cell ...
Hael Abdulrazeq +6 more
doaj +1 more source
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells
Frontiers in Endocrinology, 2020 Pituitary adenomas, accounting for 15% of diagnosed intracranial neoplasms, are usually benign and pharmacologically and surgically treatable; however, the critical location, mass effects and hormone hypersecretion sustain their significant morbidity ...
Roberto Würth +5 more
doaj +1 more source
Advanced Healthcare Materials, EarlyView.The expression of integrin β4 (ITGβ4) on small extracellular vesicle (sEV) correlates with lung‐tropism. Enrichment of ITGβ4 on sEVs enhances their lung‐targeting ability. The sEVs loaded with doxorubicin exhibit superior therapeutic efficacy in a lung metastasis mouse model.
Tung Him Ng +7 more
wiley +1 more source
Cellular Physiology and Biochemistry, 2018 Background/Aims: Long noncoding RNAs (lncRNAs) are critical regulators in various diseases including human cancer and could function as competing endogenous RNAs (ceRNAs) to regulate microRNAs (miRNAs).
Heyuan Wang +7 more
semanticscholar +1 more source
Metastatic Tumors to the Pituitary
American Journal of Ophthalmology, 1995 To illustrate how the ophthalmologist can distinguish a metastatic tumor to the pituitary from a pituitary adenoma through clinical, particularly ophthalmic, findings.We studied three patients with metastatic disease to the pituitary. One patient had a history of breast cancer without known metastatic disease, and two patients had no previous diagnosis
Matthew D. Kay +2 more
openaire +4 more sources
Advanced Materials, EarlyView.A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto +3 more
wiley +1 more source
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
OncoTarget, 2016 Purpose Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses in
Yu Mei +13 more
semanticscholar +1 more source
Advanced Sensor Research, EarlyView.Sports‐related traumatic brain injuries (TBIs) remain underdiagnosed, within amateur athletic cohorts. This review critically synthesises recent advancements in AI‐assisted neuroimaging, blood‐based biomarker profiling, wearable biosensing platforms for early detection, injury stratification, and longitudinal surveillance of TBIs.
Daniel Nicol +3 more
wiley +1 more source
Pediatric pituitary neuroendocrine tumors–a 13-year experience in a tertiary center
Frontiers in Oncology, 2023 IntroductionPediatric pituitary neuroendocrine tumor is a rare condition, and despite previous research focusing on this specific group, the main factors influencing the surgical cure rate have not been identified.MethodsWe conducted a single-center ...
Xiaoxu Li +6 more
doaj +1 more source